Xelox: all 50 studies that test it

Page 1 of 1. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.

• A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Serplulimab and Chemotherapy as First-line Treatment for Patients With RAS/BRAF-mutated Advanced Colorectal CanceNot yet recruitingNCT07622550Phase 2
• Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal CancerNot yet recruitingNCT07503639Phase 2
• Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal CancerRecruitingNCT07448142Phase 2
• A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E MutationNot yet recruitingNCT07229846Phase 2
• QL1706 Plus XELOX as Neoadjuvant Therapy for MSS/pMMR Clinical Stage III Colon CancerNot yet recruitingNCT07156682Phase 2
• Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver MetastasisNot yet recruitingNCT07007728Phase 2
• SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With OligometastasesRecruitingNCT06850103Phase 2
• LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver MetastasisRecruitingNCT06848465Phase 1
• SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.Not yet recruitingNCT06835179Phase 2
• Neoadjuvant Short-Course Radiotherapy With or Without Chemotherapy and AK112 in Locally Advanced Rectal CancerRecruitingNCT06718543Phase 2
• HDAC Inhibitor Combination with Chemoimmunotherapy in the Neoadjuvant Treatment of PMMR Locally Advanced Colon CancerRecruitingNCT06709885Phase 2
• A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)RecruitingNCT06506292Phase 2
• AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ CancerRecruitingNCT06196697Phase 2
• Treatment of Low Locally Advanced Rectal Cancer With Radiotherapy Removal TNT Plus Neoadjuvant TherapyNot yet recruitingNCT06035133Not applicable
• Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GCRecruitingNCT06023758Phase 2
• Neoadjuvant Immunotherapy in Locally Advanced Colon CancersNot yet recruitingNCT05833672Phase 2
• Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaRecruitingNCT05702229Phase 2
• SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal CancerRecruitingNCT05576480Phase 2
• Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal CancerRecruitingNCT05420584Phase 2
• Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal CancerRecruitingNCT05228431Phase 2
• Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal CancerRecruitingNCT05201430Phase 3
• Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal CancerRecruitingNCT04659382Phase 2
• Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal CancerCompletedNCT00399035Phase 3Results posted
• A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.CompletedNCT00349336Phase 3Results posted
• Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)TerminatedNCT00127036Phase 2Results posted
• Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric CancerActive, not recruitingNCT04725994Phase 1/2
• Anlotinib Hydrochloride Combined With Capeox in the Neoadjuvant Treatment of Locally Advanced Rectal CancerWithdrawnNCT04620473Phase 2
• A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal CancerActive, not recruitingNCT04543695Phase 2
• PRECISE CURATE.AI Pilot Clinical TrialStatus unknownNCT04522284Phase 1/2
• Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal CancerTerminatedNCT04495088Phase 3
• Adjuvant Chemotherapy in High Risk Stage II Colon CancerStatus unknownNCT04303429Phase 3
• PD-1 Antibody + XELOX in 1st Line Serum A-fetoprotein (AFP)-Elevated Gastric or Gastroesophageal Junction AdenocarcinomaStatus unknownNCT04098796Phase 2
• Window of Opportunity Study in Colorectal CancerCompletedNCT03984578Phase 2
• Early Evaluation of Chemosensitivity for Low/Intermediated-risk Mid-low Stage II/III Rectal CancerCompletedNCT03666442Phase 2
• Total Neoadjuvant Treatment Without Surgery For Locally Advanced Rectal CancerCompletedNCT03565029Phase 2
• XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal CancerStatus unknownNCT03511183Phase 2
• XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal CancerStatus unknownNCT03511170Phase 2
• Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal CancerStatus unknownNCT03484221Phase 2
• Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric CancerStatus unknownNCT03229096Phase 2
• Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver MetastasisCompletedNCT03031444Phase 2/3
• Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver MetastasisStatus unknownNCT02912052Phase 3
• Preoperative Chemoradiation With VMAT-SIB in Rectal CancerCompletedNCT02745639Phase 2
• Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric CancerCompletedNCT02114359Phase 3
• Neoadjuvant Sequential Therapy in Locally Advanced Mid/Low Rectal CancerStatus unknownNCT02022852Phase 2
• Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric AdenocarcinomaStatus unknownNCT01880632Phase 2
• XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC)TerminatedNCT01748851Phase 3
• Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal CancerCompletedNCT01490749Phase 1
• Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric CancerWithdrawnNCT01470742Phase 3
• Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOXCompletedNCT01396707Phase 2
• Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)CompletedNCT00387387Phase 1

← Xelox overview